NEB
Basic information
Region (hg38): 2:151485336-151734487
Previous symbols: [ "NEM2" ]
Links
Phenotypes
GenCC
Source:
- nemaline myopathy 2 (Definitive), mode of inheritance: AR
- nemaline myopathy 2 (Definitive), mode of inheritance: AR
- lethal multiple pterygium syndrome (Supportive), mode of inheritance: AR
- severe congenital nemaline myopathy (Supportive), mode of inheritance: AR
- intermediate nemaline myopathy (Supportive), mode of inheritance: AD
- typical nemaline myopathy (Supportive), mode of inheritance: AD
- childhood-onset nemaline myopathy (Supportive), mode of inheritance: AD
- nemaline myopathy 2 (Limited), mode of inheritance: AD
- nemaline myopathy 2 (Strong), mode of inheritance: AR
- nemaline myopathy 2 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Nemaline myopathy 2, autosomal recessive; Arthrogryposis multiplex congenita 6 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 10051637; 10619714; 12207937; 15221447; 16917880; 19232495; 19805734; 21798101; 22367672; 23010307; 25205138; 26578207; 27933661; 28336317; 29274205; 33376055 |
ClinVar
This is a list of variants' phenotypes submitted to
- Nemaline myopathy 2 (549 variants)
- not provided (45 variants)
- Arthrogryposis multiplex congenita 6 (40 variants)
- Nemaline myopathy (19 variants)
- NEB-related disorder (4 variants)
- Arthrogryposis multiplex congenita 6;Nemaline myopathy 2 (3 variants)
- Nemaline myopathy 2;Arthrogryposis multiplex congenita 6 (2 variants)
- Abnormality of the musculature (1 variants)
- Inborn genetic diseases (1 variants)
- Abnormality of the neck;Low-set ears;Dysphagia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 37 | 3030 | 80 | 3150 | ||
missense | 2098 | 670 | 58 | 2832 | ||
nonsense | 219 | 229 | 455 | |||
start loss | 0 | |||||
frameshift | 324 | 372 | 699 | |||
inframe indel | 87 | 90 | ||||
splice donor/acceptor (+/-2bp) | 38 | 331 | 15 | 385 | ||
splice region | 4 | 160 | 543 | 32 | 739 | |
non coding | 64 | 1439 | 96 | 1600 | ||
Total | 584 | 941 | 2311 | 5141 | 234 |
Highest pathogenic variant AF is 0.0000394
Variants in NEB
This is a list of pathogenic ClinVar variants found in the NEB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-151485444-G-A | Nemaline myopathy 2 | Uncertain significance (Jan 13, 2018) | ||
2-151485494-CCT-C | Nemaline Myopathy, Recessive | Likely benign (Jun 14, 2016) | ||
2-151485548-A-G | Nemaline myopathy 2 | Conflicting classifications of pathogenicity (Mar 01, 2023) | ||
2-151485559-T-A | Nemaline myopathy 2 | Conflicting classifications of pathogenicity (Apr 01, 2023) | ||
2-151485665-C-T | Nemaline myopathy 2 | Uncertain significance (Jan 13, 2018) | ||
2-151485703-G-A | Nemaline myopathy 2 | Uncertain significance (Jan 13, 2018) | ||
2-151485724-G-A | Nemaline myopathy 2 | Uncertain significance (Jan 12, 2018) | ||
2-151485765-T-C | Nemaline myopathy 2 | Uncertain significance (Jan 12, 2018) | ||
2-151485773-A-C | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
2-151485773-A-G | Nemaline myopathy 2 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Aug 29, 2023) | ||
2-151485774-C-A | Nemaline myopathy 2 | Uncertain significance (Nov 20, 2020) | ||
2-151485774-C-T | Nemaline myopathy 2 • NEB-related disorder | Conflicting classifications of pathogenicity (Jan 31, 2024) | ||
2-151485775-G-A | Nemaline myopathy 2 | Likely benign (Dec 21, 2022) | ||
2-151485783-C-T | Nemaline myopathy 2 • Inborn genetic diseases | Uncertain significance (Oct 04, 2022) | ||
2-151485787-G-A | Nemaline myopathy 2 | Likely benign (May 15, 2023) | ||
2-151485793-TC-T | Nemaline myopathy 2 | Uncertain significance (May 23, 2017) | ||
2-151485795-C-A | Nemaline myopathy 2 | Uncertain significance (May 23, 2017) | ||
2-151485795-C-T | Nemaline myopathy 2 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 27, 2024) | ||
2-151485796-G-A | not specified • Nemaline myopathy 2 | Benign (Feb 01, 2024) | ||
2-151485796-G-C | Nemaline myopathy 2 | Likely benign (Jul 21, 2021) | ||
2-151485798-T-C | Nemaline myopathy 2 | Likely benign (Nov 10, 2023) | ||
2-151485802-G-A | Nemaline myopathy 2 | Likely benign (Feb 24, 2023) | ||
2-151485803-C-T | Nemaline myopathy 2 | Uncertain significance (May 23, 2023) | ||
2-151485804-C-G | Nemaline myopathy 2 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jan 25, 2024) | ||
2-151485804-C-T | Nemaline myopathy 2 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NEB | protein_coding | protein_coding | ENST00000397345 | 180 | 249152 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.56e-41 | 1.00 | 124483 | 0 | 365 | 124848 | 0.00146 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0409 | 3782 | 3.77e+3 | 1.00 | 0.000208 | 56792 |
Missense in Polyphen | 1817 | 1893.8 | 0.95943 | 28149 | ||
Synonymous | -0.364 | 1373 | 1.36e+3 | 1.01 | 0.0000788 | 14549 |
Loss of Function | 11.6 | 145 | 393 | 0.369 | 0.0000205 | 5971 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00297 | 0.00286 |
Ashkenazi Jewish | 0.000902 | 0.000795 |
East Asian | 0.00137 | 0.00134 |
Finnish | 0.000978 | 0.000974 |
European (Non-Finnish) | 0.00175 | 0.00167 |
Middle Eastern | 0.00137 | 0.00134 |
South Asian | 0.00142 | 0.00137 |
Other | 0.00170 | 0.00165 |
dbNSFP
Source:
- Function
- FUNCTION: This giant muscle protein may be involved in maintaining the structural integrity of sarcomeres and the membrane system associated with the myofibrils. Binds and stabilize F-actin.;
- Pathway
- Striated Muscle Contraction;Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling;Striated Muscle Contraction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.379
Intolerance Scores
- loftool
- 0.995
- rvis_EVS
- 0.88
- rvis_percentile_EVS
- 88.9
Haploinsufficiency Scores
- pHI
- 0.149
- hipred
- N
- hipred_score
- 0.270
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.744
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Neb
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; vision/eye phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- neb
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- aggregated
Gene ontology
- Biological process
- muscle organ development;somatic muscle development;muscle filament sliding;regulation of actin filament length;muscle fiber development;cardiac muscle thin filament assembly
- Cellular component
- cytosol;actin cytoskeleton;Z disc;extracellular exosome
- Molecular function
- protein binding;structural constituent of muscle;actin filament binding